Patents by Inventor Matthew David Osborne

Matthew David Osborne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM
    Publication number: 20150329830
    Abstract: The present invention relates to a method for culturing mammalian cells in a culture medium which is transferrin free and which contains no lipophilic or synthetic nitrogen-containing chelators. Also provided is the use of the medium and a process for providing a mammalian product by culturing cells capable of producing the product in the medium.
    Type: Application
    Filed: July 22, 2015
    Publication date: November 19, 2015
    Inventors: Matthew David OSBORNE, Jonathan H. DEMPSEY
  • MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM
    Publication number: 20130183714
    Abstract: The present invention relates to a method for culturing mammalian cells in a culture medium which is transferrin free and which contains no lipophilic or synthetic nitrogen-containing chelators. Also provided is the use of the medium and a process for providing a mammalian product by culturing cells capable of producing the product in the medium.
    Type: Application
    Filed: December 20, 2012
    Publication date: July 18, 2013
    Applicant: Medimmune Limited
    Inventors: Matthew David Osborne, Jonathan H. Dempsey
  • Myeloma cell culture in transferrin-free low iron medium
    Patent number: 8361797
    Abstract: The present invention relates to a method for culturing mammalian cells in a culture medium which is transferrin free and which contains no lipophilic or synthetic nitrogen-containing chelators. Also provided is the use of the medium and a process for providing a mammalian product by culturing cells capable of producing the product in the medium.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: January 29, 2013
    Assignee: Medimmune Limited
    Inventors: Matthew David Osborne, Jonathan H. Dempsey